Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

THYROCARE TECHNOLOGIES LTD.

NSE : THYROCAREBSE : 539871ISIN CODE : INE594H01019Industry : Hospital & Healthcare ServicesHouse : MNC

BSE458.4526.2 (+6.06 %)

PREV CLOSE ( ) 432.25

OPEN PRICE ( ) 432.25

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 40404

TODAY'S LOW / HIGH ( )429.50 463.30

52 WK LOW / HIGH ( )219.33 537.97

NSE459.1526.85 (+6.21 %)

PREV CLOSE( ) 432.30

OPEN PRICE ( ) 432.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 459.15 (2626)

VOLUME 1416865

TODAY'S LOW / HIGH( ) 429.10 463.60

52 WK LOW / HIGH ( )219.33 536.67

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 28-01 2000

Management Info

- Chairman Rahul Guha - Managing Director

Registered Office

Address D - 37/1, T T C Industrial Area,M I D C,Turbhe,
Navi Mumbai,
Maharashtra-400703

Phone 022 3090 0000 / 2762 2762

Email enquiry@thyrocare.com

Website www.thyrocare.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

04Dec Thyrocare Technologies informs about d
Thyrocare Technologies has informed that the exchange has received the d..

03Dec Thyrocare Technologies informs about d
Thyrocare Technologies has informed that the exchange has received the d..

01Dec Thyrocare Technologies informs about a
Further to its earlier intimations dated October 14, 2025, and November..

29Nov Thyrocare Technologies informs about c
Pursuant to Regulation 30 read with Schedule III of the Securities and E..

12Nov Thyrocare Technologies informs about d
Thyrocare Technologies has informed that it enclosed disclosure under Re..

Financials

Rs. in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	430.3	957.8
Gross Profit	608.9	1512.1
Operating Profit	711.9	2003.6
Net Sales	2022.3	6331

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr Agarwals Eye Hsp (BSE) 5463.70 (0.14%)	M.Cap ( in Cr)2640.51
Sharma Hospitals (BSE) 139.00 (4.24%)	M.Cap ( in Cr)45.64
Fortis Healthcare (BSE) 873.85 (0.49%)	M.Cap ( in Cr)65972.02
Choksi Lab (BSE) 124.00 (2.39%)	M.Cap ( in Cr)86.37
Artemis Medicare (BSE) 283.90 (0.87%)	M.Cap ( in Cr)4491.31

Shareholding Pattern

	PROMOTERS	71.06%
	MUTUAL FUNDS/UTI	11.89%
	NON-INSTITUTION	10.63%
	FI/BANKS/INSURANCE	0.86%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Nippon India Pharma...	2.04
ICICI Pru Pharma He...	1.29
WOC Pharma and Heal...	1.24
DSP India T.I.G.E.R...	0.75
DSP Healthcare Fund...	0.74
Quant Small Cap Fund(G)	0.35
Nippon India Small ...	0.28

Risk Disclosures on Derivatives

Smart Quotes

THYROCARE TECHNOLOGIES LTD.